Effect of low-dose atropine on young premyopic and low-myopic children: atropine treatment of myopia (ATOM3) - a randomised control trial. [PDF]
Chia A +8 more
europepmc +1 more source
Therapeutic Effect of Topical 0.125% Atropine in South Korean Myopic Children: A Real-World Experience. [PDF]
Kim DH +6 more
europepmc +1 more source
IMI-Instrumentation for Myopia Management. [PDF]
Jones D +7 more
europepmc +1 more source
Prediction of myopia based on biometric parameters of 500,000 children and adolescents aged 3-18 years. [PDF]
Chen S, Mu J, Tan X, Wu X, Duan J.
europepmc +1 more source
Comparison between cycloplegic and noncycloplegic refraction in young adult myopes. [PDF]
Khan HA +5 more
europepmc +1 more source
Myopic Progression Associated with COVID-19 Pandemic in Korean Children with Myopia Using 0.01% Atropine Eyedrops. [PDF]
Kim DH, Park J, Hwang JM, Yang HK.
europepmc +1 more source
Myopia prevalence among primary school students across different districts in Guangzhou: insights from a large-scale school-based screening. [PDF]
Zhang X +4 more
europepmc +1 more source
Accommodative responses in children with high and low levels of astigmatism. [PDF]
Haensel JX +12 more
europepmc +1 more source
Predicting Cycloplegic Spherical Equivalent Refraction Among Children and Adolescents Using Non-cycloplegic Data and Machine Learning - China, 2020-2024. [PDF]
Liu K +7 more
europepmc +1 more source
Comparing Close-Field and Open-Field Autorefractometry and Subjective Refraction. [PDF]
Noya-Padin V +5 more
europepmc +1 more source

